Itron (ITRI) director Timothy Leyden receives 232-share board grant

Rhea-AI Filing Summary

LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.

Itron, Inc. director Timothy M. Leyden received a grant of 232 shares of common stock as part of the quarterly compensation that independent board members receive. The award was at no cash cost per share and increased his direct holdings to 16,005 shares.

According to the disclosure, Leyden deferred receipt of 87 of these shares under Itron's Executive Deferred Compensation Plan, so only part of the award was taken immediately in stock while the remainder was deferred.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LEYDEN TIMOTHY M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	232	$0.00	--

Holdings After Transaction: Common Stock — 16,005 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Director stock grant: 232 shares Holdings after grant: 16,005 shares Deferred shares: 87 shares

3 metrics

Director stock grant 232 shares Common stock awarded as quarterly board compensation

Holdings after grant 16,005 shares Timothy M. Leyden direct common stock ownership after transaction

Deferred shares 87 shares Portion of grant deferred under Executive Deferred Compensation Plan

Key Terms

Grant, award, or other acquisition, Executive Deferred Compensation Plan, independent members of Itron's board of directors

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Executive Deferred Compensation Plan financial

"Mr. Leyden deferred receipt of 87 shares pursuant to Itron's Executive Deferred Compensation Plan."

independent members of Itron's board of directors financial

"Reflects the grant of common stock independent members of Itron's board of directors receive quarterly"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEYDEN TIMOTHY M

(Last) (First) (Middle)

2111 N. MOLTER ROAD

(Street)

LIBERTY LAKE WASHINGTON 99019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		232(1)	A	$0	16,005	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 87 shares pursuant to Itron's Executive Deferred Compensation Plan.

	/s/ Christopher E. Ware, attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Itron (ITRI) disclose for Timothy M. Leyden?

Itron reported that director Timothy M. Leyden received a grant of 232 shares of common stock as part of quarterly board compensation. The award was recorded as a grant or other acquisition, not an open-market purchase or sale, under standard director compensation arrangements.

How many Itron (ITRI) shares does Timothy M. Leyden hold after this grant?

After the grant, Timothy M. Leyden directly holds 16,005 shares of Itron common stock. This figure reflects his position following receipt of the 232-share compensation award, combining his prior holdings with the new shares credited in this routine director grant.

Was cash paid for the Itron (ITRI) shares granted to Timothy M. Leyden?

No cash was paid for this award. The 232-share grant to Timothy M. Leyden carried a reported price of $0.0000 per share, indicating the shares were issued as non-cash equity compensation for his service on Itron’s board of directors.

Did Timothy M. Leyden defer any of his Itron (ITRI) share grant?

Yes. Leyden deferred receipt of 87 of the 232 granted shares under Itron’s Executive Deferred Compensation Plan. This means a portion of his director compensation will be delivered later under that plan’s terms, rather than as immediately received stock.

Is Timothy M. Leyden’s Itron (ITRI) Form 4 transaction a purchase or a grant?

The transaction is classified as a grant, award, or other acquisition, coded as an “A” transaction. It represents equity compensation for board service, not an open-market stock purchase or sale, and therefore reflects routine director pay practices at Itron.